Honda, Michitaka
Kumamaru, Hiraku
Etoh, Tsuyoshi
Miyata, Hiroaki
Yamashita, Yuichi
Yoshida, Kazuhiro
Kodera, Yasuhiro
Kakeji, Yoshihiro
Inomata, Masafumi
Konno, Hiroyuki
Seto, Yasuyuki
Kitano, Seigo
Watanabe, Masahiko
Hiki, Naoki http://orcid.org/0000-0002-6857-8736
Article History
Received: 30 September 2018
Accepted: 5 November 2018
First Online: 11 December 2018
Compliance with ethical standards
:
: All study procedures were conducted in accordance with the ethical standards of the respective committees on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. The study was approved by the Institutional Review Board of Cancer Institute Hospital, Japanese Foundation for Cancer Research.
: Dr. Kodera reports grants and personal fees from Taiho Pharmaceutical, grants and personal fees from Chugai Pharmaceutical, grants from Sanofi, grants from Merck Serono, grants and personal fees from Yakult Honsha, grants from Daiichi Sankyo, grants and personal fees from Otsuka Pharmaceutical Factory, grants from Takeda Pharmaceutical, personal fees from Johnson & Johnson, personal fees from Asahi Kasei Pharma, grants and personal fees from Eli Lilly Japan, grants from Pfizer Japan, grants from EA Pharmaceuticals, grants and personal fees from ONO Pharmaceutical, grants and personal fees from Kaken Pharmaceutical, grants from Covidien Japan, grants from Shionogi, grants from Bristol-Myers Squibb, grants from Japan Blood Products Organization, grants from AbbVie GK, grants from Otsuka Pharmaceutical, grants from Eizai, grants from Abbott Japan, grants from CSL Behring, grants from Tsumura, grants from Nippon Kayaku, grants from Novartis Pharmaceuticals Japan, grants from KCI, grants from Maruho, personal fees from MSD, outside the submitted work.